Variant report
Variant | nsv604142 |
---|---|
Chromosome Location | chr6:92999553-93068305 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:93025598..93027603-chr6:93032069..93034381,2 | K562 | blood: | |
2 | chr6:93030191..93031984-chr6:93042467..93044546,2 | MCF-7 | breast: | |
3 | chr6:93030191..93031984-chr6:93042467..93044546,2 | MCF-7 | breast: | |
4 | chr6:93040169..93042395-chr6:93071437..93074372,2 | K562 | blood: | |
5 | chr6:93025598..93027603-chr6:93032069..93034381,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs559937806 | chr6:93011613-93011614 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs146875171 | chr6:93011619-93011620 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs553772076 | chr6:93011625-93011626 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs180880310 | chr6:93011628-93011629 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs140735691 | chr6:93011635-93011636 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs555825753 | chr6:93011637-93011638 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs145770696 | chr6:93011641-93011642 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs535925129 | chr6:93011661-93011662 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs1596490 | chr6:93011724-93011725 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs76426032 | chr6:93011738-93011739 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs536122273 | chr6:93011759-93011760 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs138282493 | chr6:93011769-93011770 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs552019840 | chr6:93011777-93011778 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs568911682 | chr6:93011784-93011785 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs572660501 | chr6:93011797-93011798 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs140841510 | chr6:93011857-93011858 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs541350067 | chr6:93011871-93011872 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs9345225 | chr6:93011914-93011915 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs561379317 | chr6:93011938-93011939 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs367819024 | chr6:93011975-93011976 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs530017935 | chr6:93011992-93011993 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs6911336 | chr6:93012010-93012011 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs183468664 | chr6:93012015-93012016 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs563737672 | chr6:93012016-93012017 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs538077011 | chr6:93012035-93012036 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs115176891 | chr6:93012037-93012038 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs143083200 | chr6:93012073-93012074 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs148181834 | chr6:93012093-93012094 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs189380538 | chr6:93012094-93012095 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs1947048 | chr6:93012151-93012152 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
31 | rs535811741 | chr6:93012186-93012187 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs555864638 | chr6:93012208-93012209 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs575687310 | chr6:93012209-93012210 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs142697759 | chr6:93012240-93012241 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs181986874 | chr6:93012317-93012318 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs12660866 | chr6:93012323-93012324 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs186171023 | chr6:93012325-93012326 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs192072861 | chr6:93012328-93012329 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs147363797 | chr6:93012377-93012378 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs111952480 | chr6:93012388-93012389 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs546523670 | chr6:93012394-93012395 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs142704724 | chr6:93038220-93038221 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs562160443 | chr6:93038250-93038251 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs147603423 | chr6:93038256-93038257 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs544708598 | chr6:93038262-93038263 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs376070127 | chr6:93038285-93038286 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs560612561 | chr6:93038294-93038295 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs4304134 | chr6:93038298-93038299 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs560728664 | chr6:93038335-93038336 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs527388321 | chr6:93038397-93038398 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Autism | 22495311 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16272173 | CNVD |
Prostate cancer | 18632612 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Wilms tumour | 21544195 | CNVD |
Follicular lymphoma | 17699855 | CNVD |
Breast cancer | 17133270 | CNVD |
Leukemia | 18688285 | CNVD |
Prostate cancer | 19242612 | CNVD |
Glioma | 21046410 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Zellweger syndrome | 21572526 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Prostate cancer | 17245344 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Cancer | 20164920 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 17640729 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Chondromyxoid Fibroma | 20696777 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Breast cancer | 21364760 | CNVD |
Developmental delay | 19490664 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Adrenocortical carcinoma | 18281524 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Neuropathy | 19664229 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Ovarian cancer | 21720365 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:93011600-93012400 | Enhancers | Fetal Heart | heart |
2 | chr6:93038200-93040400 | Enhancers | Hela-S3 | cervix |
3 | chr6:93039000-93039600 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
4 | chr6:93040400-93047800 | Weak transcription | Hela-S3 | cervix |
5 | chr6:93043600-93044000 | Enhancers | Stomach Mucosa | stomach |
6 | chr6:93044000-93045000 | Weak transcription | Stomach Mucosa | stomach |
7 | chr6:93045000-93045600 | Enhancers | Stomach Mucosa | stomach |
8 | chr6:93045600-93050600 | Weak transcription | Stomach Mucosa | stomach |
9 | chr6:93047800-93052400 | Enhancers | Hela-S3 | cervix |
10 | chr6:93049000-93050200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
11 | chr6:93050200-93050600 | Flanking Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
12 | chr6:93050600-93051000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
13 | chr6:93050600-93052000 | Enhancers | Muscle Satellite Cultured Cells | -- |
14 | chr6:93050800-93051000 | Enhancers | Stomach Mucosa | stomach |
15 | chr6:93052400-93064000 | Weak transcription | Hela-S3 | cervix |
16 | chr6:93059800-93060200 | Enhancers | Pancreatic Islets | Pancreatic Islet |
17 | chr6:93064000-93064400 | Enhancers | Adipose Nuclei | Adipose |
18 | chr6:93064000-93064400 | Enhancers | Hela-S3 | cervix |
19 | chr6:93064000-93064600 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |